| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498055 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 32 Pages |
Abstract
This study demonstrates that IO-LDRB is an effective treatment option for patients with low and low-tier intermediate-risk prostate cancer. Rates of biochemical relapse remain low several years after treatment. These results compared favorably to published manual preplan technique results.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kevin MD, Siraj MD, Daniel MD, Steve MD, Guila MD, Philippe MD, Luc PhD, Andre-Guy MD, Eric MD,